MDXG · Nasdaq · CIK 0001376339

MIMEDX GROUP, INC.

MIMEDX GROUP, INC.’s most recent SEC filing in our snapshot is a Form 425 filed on Oct 16, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $418.6M and net income of $48.6M, according to its XBRL data on EDGAR. Its EDGAR record lists 19 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$418.6M
Net income, FY2025
$48.6M
Form 4 filings on record, past 12 months
19

Company overview

Legal name (as filed)
MIMEDX GROUP, INC.
Ticker
MDXG
SEC Central Index Key (CIK)
0001376339
Business address
MARIETTA, GA
State or country of incorporation
—
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#2835 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from MIMEDX GROUP, INC.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$242.0MFY2021$267.8MFY2022$321.5MFY2023$348.9MFY2024$418.6MFY2025
Net income
-$10.3MFY2021-$30.2MFY2022$58.2MFY2023$42.4MFY2024$48.6MFY2025
MDXG annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$242.0M$267.8M$321.5M$348.9M$418.6M
Net income-$10.3M-$30.2M$58.2M$42.4M$48.6M
Diluted EPS-$0.15-$0.33$0.37$0.28$0.32
Total assets$187.9M$171.4M$239.0M$263.9M$342.7M
Cash and equivalents$87.1M$66.0M$82.0M$104.4M$166.1M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

MDXG latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 25, 202610-KAnnual report· period Dec 31, 2025Document · Index
Jul 29, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 16, 20268-KOther events· period Oct 15, 2026Document · Index
Apr 29, 2026DEF 14ADefinitive proxy statement· period Dec 31, 2025Document · Index

Recent SEC filings

The 40 newest documents filed by or about MIMEDX GROUP, INC., by form type:

4 ×17425 ×88-K ×610-Q ×2EFFECT ×1424B3 ×1S-4 ×18-K/A ×1DEFA14A ×1ARS ×1DEF 14A ×1
MDXG recent filings
FiledFormWhat it isOriginal
Oct 16, 2026425CURRENT REPORTDocument · Index
Oct 16, 20268-KOther events· period Oct 15, 2026Document · Index
Sep 4, 2026EFFECTEFFECTDocument · Index
Sep 4, 2026424B3PROSPECTUSDocument · Index
Aug 25, 2026S-4REGISTRATION STATEMENTDocument · Index
Aug 11, 2026425425Document · Index
Aug 11, 20268-K/AMaterial agreement; Regulation FD disclosure· period Jul 29, 2026Document · Index
Jul 30, 2026425425Document · Index
Jul 30, 2026425425Document · Index
Jul 29, 2026425425Document · Index
Jul 29, 20268-KResults of operations; Regulation FD disclosure· period Jul 29, 2026Document · Index
Jul 29, 2026425425Document · Index
Jul 29, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Jul 29, 20268-KMaterial agreement; Regulation FD disclosure· period Jul 29, 2026Document · Index
Jul 29, 2026425425Document · Index
Jul 29, 2026425425Document · Index
Jul 7, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 2, 2026Document · Index
Jun 25, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 24, 2026Document · Index
Jun 16, 20268-KCharter, bylaws or fiscal year change; Shareholder vote results· period Jun 10, 2026Document · Index
Jun 12, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026Document · Index
Jun 12, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026Document · Index
Jun 12, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026Document · Index
Jun 12, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026Document · Index
Jun 12, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026Document · Index
Apr 29, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Apr 29, 2026ARSARS· period Dec 31, 2025Document · Index
Apr 29, 2026DEF 14ADefinitive proxy statement· period Dec 31, 2025Document · Index
Apr 29, 20268-KResults of operations; Regulation FD disclosure· period Apr 29, 2026Document · Index
Apr 29, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Apr 16, 20268-KDirector or officer change; Regulation FD disclosure· period Apr 14, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 17, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 13, 2026Document · Index
Mar 12, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 10, 2026Document · Index
Mar 12, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 10, 2026Document · Index
Mar 12, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 10, 2026Document · Index
Mar 6, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 4, 2026Document · Index
Mar 6, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 4, 2026Document · Index
Mar 6, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 4, 2026Document · Index
Mar 6, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 4, 2026Document · Index
Mar 6, 20264Statement of changes in beneficial ownership (insider trade)· period Mar 4, 2026Document · Index

Insider filing activity

19 Form 4 filings appear in MIMEDX GROUP, INC.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in Georgia

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001376339 and XBRL company facts. MIMEDX GROUP, INC. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.